Niagen Bioscience (NAGE) traded down -3.57 % during a 24 hours period ending at 03:02 AM Central Europe on Tuesday 27th. One Niagen Bioscience stock can currently be bought for about USD 2.44 on popular exchanges. Current supply of Niagen Bioscience stocks is 79.6 mn. Niagen Bioscience has a current market capitalization of USD 193.5 mn and approximately USD 1.3 mn worth of Niagen Bioscience was traded on exchanges in the last 24 hours. Since last month end, Niagen Bioscience has traded -19.27 % down. Simple moving average of last 200 days is at USD 4.02. The highest price of past 52 weeks was recorded at USD 7.95 on 11/05/2025. 52 weeks low was at USD 2.42 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Peoples Of Nc (PEBK) traded down -0.96 % and now trades at USD 43.57. Current market capitalisation for Peoples Of Nc is USD 231.4 mn. Peoples Of Nc has a current price to earnings ratio of 10.95.
Stellar V Capital (SVCC) traded flat 0 % and now trades at USD 10.68. Current market capitalisation for Stellar V Capital is USD 231.7 mn.
Lexeo Therapeutics (LXEO) traded down -3.11 % and now trades at USD 2.7. Lexeo Therapeutics has a market capitalisation of USD 229.7 mn.
Palisade Bio (PALI) traded down -1.48 % and now trades at USD 1.23. Current market capitalisation for Palisade Bio is USD 231.8 mn.
Graftech (EAF) traded up 14.23 % and now trades at USD 10.65. Current market capitalisation for Graftech is USD 228.9 mn.
About Niagen Bioscience
ChromaDex Corporation is a health care company operating in the life sciences tools and services sector with its main base located in Los Angeles, United States. The company is actively involved in research related to nicotinamide adenine dinucleotide, a significant factor in healthy aging studies. ChromaDex provides services and resources for customers residing within the United States, governed by the Nasdaq stock exchange. The official website for the company is accessible under www.chromadex.com .
